Inspire Medical Systems Earnings Preview: Analyst Estimates and Historical Performance
ByAinvest
Saturday, Aug 2, 2025 2:49 am ET1min read
INSP--
Historically, Inspire Medical Systems has a track record of beating EPS estimates. In the last reported quarter, the company delivered an EPS surprise of +143.48%, beating expectations by $0.33 [1]. This performance was followed by a 1.98% increase in share price the next day. Over the last four quarters, the company has beaten consensus EPS estimates four times.
Analysts have given Inspire Medical Systems a consensus rating of Outperform, with an average one-year price target of $197.33, suggesting a potential 58.45% upside [2]. The company ranks at the top for revenue growth and gross profit among its peers, but it has the lowest return on equity [2].
Inspire Medical Systems operates as a medical technology company, focusing on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). The company's Inspire system is a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.
The company's market capitalization is positioned below industry averages, which could be attributed to factors such as growth expectations or operational capacity [2]. Revenue growth for the company was approximately 22.75% as of 31 March 2025, indicating a notable increase in top-line earnings.
Investors should pay attention to other factors beyond the earnings beat or miss, as these are not the sole determinants of a stock's performance. The company's Earnings ESP of +9.09% and Zacks Rank of #3 suggest that Inspire is likely to beat the consensus EPS estimate [1]. However, the sustainability of the immediate price change and future earnings expectations will depend on management's discussion of business conditions on the earnings call.
References:
[1] https://finance.yahoo.com/news/inspire-medical-systems-insp-expected-140013342.html
[2] https://www.benzinga.com/insights/earnings/25/08/46800844/uncovering-potential-inspire-medical-systemss-earnings-preview
Inspire Medical Systems is set to announce its quarterly earnings on August 4, 2025. Analysts estimate an EPS of $0.21. Historically, the company has beaten EPS estimates and seen a 1.98% increase in share price. Inspire Medical Systems has received a total of 6 ratings from analysts, with a consensus rating of Outperform and a potential 58.45% upside.
Inspire Medical Systems (INSP) is set to announce its quarterly earnings on August 4, 2025. Analysts estimate an EPS of $0.21, which represents a year-over-year decline of -31.3% [1]. While revenues are expected to increase by 9.8% to $215.05 million, the earnings outlook indicates a challenging quarter for the company.Historically, Inspire Medical Systems has a track record of beating EPS estimates. In the last reported quarter, the company delivered an EPS surprise of +143.48%, beating expectations by $0.33 [1]. This performance was followed by a 1.98% increase in share price the next day. Over the last four quarters, the company has beaten consensus EPS estimates four times.
Analysts have given Inspire Medical Systems a consensus rating of Outperform, with an average one-year price target of $197.33, suggesting a potential 58.45% upside [2]. The company ranks at the top for revenue growth and gross profit among its peers, but it has the lowest return on equity [2].
Inspire Medical Systems operates as a medical technology company, focusing on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). The company's Inspire system is a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.
The company's market capitalization is positioned below industry averages, which could be attributed to factors such as growth expectations or operational capacity [2]. Revenue growth for the company was approximately 22.75% as of 31 March 2025, indicating a notable increase in top-line earnings.
Investors should pay attention to other factors beyond the earnings beat or miss, as these are not the sole determinants of a stock's performance. The company's Earnings ESP of +9.09% and Zacks Rank of #3 suggest that Inspire is likely to beat the consensus EPS estimate [1]. However, the sustainability of the immediate price change and future earnings expectations will depend on management's discussion of business conditions on the earnings call.
References:
[1] https://finance.yahoo.com/news/inspire-medical-systems-insp-expected-140013342.html
[2] https://www.benzinga.com/insights/earnings/25/08/46800844/uncovering-potential-inspire-medical-systemss-earnings-preview
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet